Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
We examined risk associated with antibiotics used for Clostridioides difficile infection (CDI) at a single site from 2018 through 2020. Overall, 78 patients had nonrecurrent infections. Among inpatient antibiotics, intravenous meropenem had the highest CDI rate (3.56 per 1,000 days of therapy; n = 2...
Main Authors: | Andrew T. Dysangco, Tamra M. Pierce, Dawn M. Bravata |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-01-01
|
Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X22002868/type/journal_article |
Similar Items
-
Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network.
by: Sarah Rhea, et al.
Published: (2020-01-01) -
The microbial diversity following antibiotic treatment of Clostridioides difficile infection
by: Dana Binyamin, et al.
Published: (2021-04-01) -
Impact of a Diagnosis-Centered Antibiotic Stewardship on Incident <i>Clostridioides difficile</i> Infections in Older Inpatients: An Observational Study
by: Alain Putot, et al.
Published: (2020-06-01) -
Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
by: Layan Abu Rahmoun, et al.
Published: (2021-08-01) -
Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals
by: R. Douglas Scott, et al.
Published: (2019-01-01)